🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Dolutegravir (DTG) and lamivudine (3TC) are indicated in combination with o...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-05
Trial ID
NCT02738931
This is a non-inferiority (10% non-inferiority margin), study to assess the...
Status
Completed
Location
Shandukani Research Centre
Start Date
2017-01-16
Trial ID
NCT03122262
Treatments Being Tested
i2-D²EFT substudy is an observational cohort nested within the parent D²EFT...
Status
Withdrawn
Location
Multiple Locations
Start Date
2021-02-01
Trial ID
NCT04183738
Treatments Being Tested
Dolutegravir (DTG), a human immunodeficiency virus (HIV)-1 integrase inhibi...
Status
Completed
Location
GSK Investigational Site
Start Date
2019-06-17
Trial ID
NCT03984838
Treatments Being Tested
Background: People with HIV take drugs to keep the amount of virus in thei...
Status
Recruiting
Location
National Institutes of Health Clinical Center
Start Date
2026-09-02
Trial ID
NCT05652478
Protocol Number: FH-94 Study Objetives: Primary: * To evaluate the virol...
Status
Not Yet Recruiting
Location
Hospital General de Agudos Dr. Cosme Argerich
Start Date
2026-06-15
Trial ID
NCT07616739
The First Long-Acting Injectable Regimen (FLAIR) study is being conducted t...
Status
Active Not Recruiting
Location
GSK Investigational Site
Start Date
2016-10-27
Trial ID
NCT02938520
This is a single-center, open label study to identify adherence levels of c...
Status
Completed
Location
HIV/AIDS Clinical Research Unit / University of Pittsburgh
Start Date
2020-08-31
Trial ID
NCT04302896
This cluster-randomized intervention is embedded in the ComBaCaL (Community...
Status
Not Yet Recruiting
Location
SolidarMed Lesotho
Start Date
2026-06
Trial ID
NCT07581600
Treatments Being Tested
D²EFT is a randomised, open-label study in HIV-1 infected patients failing ...
Status
Unknown
Location
Hospital Dr Diego Paroissien
Start Date
2017-11-23
Trial ID
NCT03017872
Treatments Being Tested